FSD Pharma Inc Institutionelles Eigentum
Was ist das Institutionelles Eigentum von FSD Pharma Inc?
Institutionelles Eigentum von FSD Pharma Inc ist 1.30%
Was ist die Definition von Institutionelles Eigentum?
Institutionelles Eigentum ist der Betrag der verfügbaren Aktien eines Unternehmens, das sich im Besitz von Investmentfonds oder Pensionskassen, Versicherungsgesellschaften, Wertpapierfirmen, Stiftungen oder anderen großen Körperschaften befindet, die Fonds für Dritte verwalten.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Institutionelles Eigentum von Unternehmen in Technology Sektor auf NASDAQ im Vergleich zu FSD Pharma Inc
Was macht FSD Pharma Inc?
fsd pharma inc., through its subsidiary, fv pharma inc., produces medical cannabis in canada. the company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, gi tract, and musculoskeletal system, such as chronic pain. fsd pharma inc. has strategic alliance agreements with scicann therapeutics inc., canntab therapeutics, and solarvest bioenergy inc. the company was founded in 1998 and is headquartered in toronto, canada.
Unternehmen mit institutionelles eigentum ähnlich FSD Pharma Inc
- Digjam hat Institutionelles Eigentum von 1.29%
- Digjam hat Institutionelles Eigentum von 1.29%
- Telefonica S.A hat Institutionelles Eigentum von 1.29%
- Clear Blue Technologies International hat Institutionelles Eigentum von 1.29%
- Longevity Acquisition hat Institutionelles Eigentum von 1.30%
- Greenland Technologies Corp hat Institutionelles Eigentum von 1.30%
- FSD Pharma Inc hat Institutionelles Eigentum von 1.30%
- Chevalier International hat Institutionelles Eigentum von 1.30%
- Lippo hat Institutionelles Eigentum von 1.30%
- BioSyent hat Institutionelles Eigentum von 1.30%
- China Development hat Institutionelles Eigentum von 1.30%
- Clear Blue Technologies International hat Institutionelles Eigentum von 1.30%
- HeraMED hat Institutionelles Eigentum von 1.31%